mAbxience Welcomes Jurgen Van Broeck as New CEO
mAbxience, a company in the pharmaceutical industry, has announced the appointment of Jurgen Van Broeck as its new Chief Executive Officer. Broeck, who has been…
mAbxience, a company in the pharmaceutical industry, has announced the appointment of Jurgen Van Broeck as its new Chief Executive Officer. Broeck, who has been…
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd., and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, have…
mAbxience is a Pharmaceutical company, CMO/CDMO, Biopharmaceutical company, Contract Research Organisation (CRO), Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry. mAbxience is a global biotech…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.